Immunome, Inc. (IMNM)
22.12
+0.32
(+1.47%)
USD |
NASDAQ |
Feb 24, 16:00
22.12
0.00 (0.00%)
Pre-Market: 20:00
Immunome Shareholders Equity (Annual) : 181.16M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Prelude Therapeutics, Inc. | 131.46M |
| Eli Lilly & Co. | 26.54B |
| Relay Therapeutics, Inc. | 777.79M |
| Context Therapeutics, Inc. | 95.27M |
| Moderna, Inc. | 8.65B |